Share this page | Email | Contact Us

Special Report on

Patient Recruitment in Clinical Trials

patient recruitment in clinical trials special research report Photo by
is the second edition of our research of the sector and thus it offers you a unique opportunity to keep track of market trends and developments over the last several years. It provides a comprehensive study of the sector, with data on its value and development prospects. Based on a recent PMR research and exclusive interviews with experts in the field, the report reveals the attitudes of managers of over 100 pharmaceutical companies and CROs towards the market, and situates Poland’s clinical trials in the context of other CEE countries. A database of over 60 CROs active on the Polish market is also added to the report as a ...
Patient enrollment is the most time-consuming aspect of the clinical trial process. The leading cause of missed clinical trial deadlines is patient recruitment, taking up to 30 percent of the clinical timeline. Improving patient recruitment rates offers pharmaceutical and medical device companies one of the biggest opportunities to accelerate the pace of clinical trials – making it possible to reduce time to market . As the number of patients needed for clinical trails rises – as safety and regulatory issues drive trends toward larger and longer trials – the demand for patient recruitment services grows. Clinical trials are ...
Exco intouch Partners With Logos Technologies To Improve Patient ...
Exco InTouch, the leading mobile messaging provider for the pharmaceutical industry, announces that it has partnered with London-based Logos Technologies, experts in early phase EDC and Phase I site automation, to develop an integrated system which speeds up the patient recruitment process. The integration of Exco InTouch’s short messaging service (SMS) technology, ATLAS™, with ALPHADAS®, Logos Technologies’ proprietary electronic data capture (EDC) system, enables clinical trials sponsors and investigators to quickly identify, contact and assess relevant patients for early phase studies. The collaboration between Logos ... market research, surveys and trends
Clinical Trials: Upcoming Conference
"Patient recruitment and retention are critical to drug development programs. Patient recruitment if not adequately planned for can extend your development timeline by a number of years. Retention of patients throughout the life of a clinical trial is essential in order have complete data sets for your analysis and subsequent filings. In order to optimize both you have to have a plan. This conference is intended to cover the topics one should consider when drafting and strategically implementing a patient recruitment and retention plan for a clinical development program." Please see conference webpage for details. Labels: market research, surveys and trends


A Marketing-Centric Approach to Patient Recruitment in Clinical Trials
More than seventy-five percent of all US clinical trials from 1993 to 1998 missed ... as much as $5.4 million for a blockbuster like ... industry trends, business articles and survey research
Developing a Statewide Clinical Trial Registry for Georgia - The ...
Biotechnology research is emerging in Georgia through a financially buoyant and talented pool of professionals who bring great science, technology and jobs to the state. This industry is typically cost-effective for medical innovation while exploring novel products that can save millions of lives. Speaking at the launch of a Georgia-grown research partnership recently, Gov. Sonny Perdue noted, �This partnership demonstrates the strengths Georgia provides industry through collaborations among its research universities, health care organizations and the Georgia Research Alliance." This clear endorsement, combined ... industry trends, business articles and survey research
India is poised to be in the forefront of outsourcing by pharma companies
Indian companies have made great strides in the global arena across different business segments. They have also demonstrated their ability to play the leader�s role in each of the segments. Globally, it has been observed that India is emerging as a preferred destination for pharmaceutical companies� outsourcing venture of drug discovery, clinical research and contract manufacturing functions. According to a study by PriceWaterhouseCoopers (PwC) on the changing dynamics of pharma outsourcing to Asia, India is being recognized as the best outsourcing pharma destination, followed by Korea and Taiwan. Currently, the Indian pharma ... market trends, news research and surveys resources
Algeta results for the second quarter and first half 2010
Aug 13, 2010 (Thomson Reuters ONE via COMTEX) -- Oslo, Norway, 13 August 2010 - Algeta ASA (OSE: ALGETA), the focused oncology company, today announces its results for the second quarter and the six months ending 30 June 2010. A presentation of the results will be webcast live from submitted live during the presentation. Highlights of the second quarter 2010: * Algeta and its partner Bayer Schering Pharma AG ("Bayer") decided to increase recruitment for the ALSYMPCA phase III trial of Alpharadin (radium 223 chloride) for treating bone metastases arising ... market trends, news research and surveys resources


Accelerating Patient Recruitment in Clinical Trials
Accelerating Patient Recruitment in Clinical Trials. First published July 2006 by NetworkPharma Ltd,. 89 Oxford Road, Oxford OX2 9PD, UK ... technology research, surveys study and trend statistics
Recruiting Human Subjects: Pressures in Industry-Sponsored ...
research process, the recruitment of subjects into clinical trials. .... coordinators, and patient recruitment firms. In general, sponsors use healthy ... technology research, surveys study and trend statistics
Howard Mann - Therapeutic Beneficence and Patient Recruitment in ...
Miller and Brody (2002) offer a critique of the argument from therapeutic obligation advanced by proponents of the role of clinical equipoise in clinical trials by proposing a sharp distinction between the objectives in clinical care and in a randomized controlled trial (RCT): individualized treatment recommendations expressive of the principle of therapeutic beneficence, and accumulation of scientifically valid data, respectively. They imply that these disparate objectives cannot simultaneously be pursued in the context of an RCT and point to "conflicts between patient welfare and scientific investigation, inherent in clinical ...
latest webinars
  1. Webinar and Audioconferences
  2. Dia feb 2010 final presentation webinar 2 mll
Join these Webinars to learn more about current research, trends and surveys.
Question: clinical trials
Hi Gillammi, The average cost to recruit a patient for a clinical trial is $2,000. "The average recruitment cost per subject in clinical trials is approximately $2,000. (. . .) "Patient recruitment represents the $1.3 billion upfront cost of the annual $10 billion clinical trial industry." Source: Future Pharmaceuticals "Informed Consent Upgraded and Uploaded", Q3 2006 From a paper documenting recruitment for a Estrogen Replacement and Atherosclerosis trial: "Overall, screening and recruitment averaged $2508 per ...
What techniques do you use to boost patient recruitment and ...
Make a simple comment OR take the survey linked below - everyone who completes one will get the report - AND be entered into a champagne draw. It will only take 10 mins. posted 2 months ago in Planning | Closed Share This Principal Consultant at CODE Purple see all my answers Very simple and easy to fill in - did so from an East European perspective which tends to make results much more positive - patient recruitment/retention is not such an issue. posted 2 months ago